Understand the source comparison
Best Time Take FOXO4-DRI Morning Night: Comparison
Morning (6:00–9:00 AM, fasted 8+ hours) Peak LC3-II/SQSTM1 expression. Autophagy flux 200–300% higher than evening p53 protein levels peak due to circadian MDM2 suppression Requires overnight fast and 30–45 min delay before breakfast Optimal cellular uptake an
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Morning (6:00–9:00 AM, fasted 8+ hours)
- Peak LC3-II/SQSTM1 expression. Autophagy flux 200–300% higher than evening
- p53 protein levels peak due to circadian MDM2 suppression
- Requires overnight fast and 30–45 min delay before breakfast
- Optimal cellular uptake and senolytic efficacy. Align peptide administration with natural autophagy and p53 peaks
- Late morning (9:00 AM–12:00 PM, fasted 4–6 hours)
- Moderate autophagy activity. Declining as circadian BMAL1/CLOCK expression drops
- p53 still elevated but beginning to decline toward midday nadir
- More flexible for those who can't maintain 8-hour overnight fast
- Acceptable alternative. Still captures partial circadian benefit if full morning fast is impractical
- Evening (6:00–9:00 PM, any feeding state)
- Autophagy suppressed by PER2 gene expression and postprandial insulin signaling
- p53 protein levels lowest due to peak MDM2 activity in evening
- Convenient for those with rigid morning schedules
- Suboptimal. 30–40% reduction in cellular uptake and senescent cell clearance compared to morning dosing
- Pre-bed (10:00 PM–12:00 AM, fasted 2–3 hours)
- Minimal autophagy flux. Circadian suppression compounded by recent feeding
- p53 at daily nadir. Lowest sensitivity to FOXO4 disruption
- Avoids morning scheduling but sacrifices circadian alignment
- Not recommended. Combines worst circadian timing with insufficient fasting duration